Suppr超能文献

现患椎体骨折、骨密度及阿仑膦酸盐治疗与新发椎体骨折的关联:骨折数量及脊柱部位的影响。骨折干预试验研究组

Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group.

作者信息

Nevitt M C, Ross P D, Palermo L, Musliner T, Genant H K, Thompson D E

机构信息

University of California, Prevention Sciences Group, San Francisco 94105, USA.

出版信息

Bone. 1999 Nov;25(5):613-9. doi: 10.1016/s8756-3282(99)00202-1.

Abstract

Vertebral fractures are the most common osteoporotic fracture and are associated with significant pain and disability. Prior vertebral fracture and low bone mineral density (BMD) are strong predictors of new vertebral fracture. Using data from 6082 women, ages 55-80 years, in the Fracture Intervention Trial (a randomized, placebo-controlled trial of the antiresorptive agent, alendronate), we explored the association of the number of prior vertebral fractures with the risk of new fractures and whether this association is influenced by the spinal location of fractures. The risk of future vertebral fractures increased with the number of prevalent fractures, independently of age and BMD; in the placebo group, more than half of the women with five or more fractures at baseline developed new vertebral fractures, compared to only 3.8% of women without prior vertebral fractures. The magnitude of association with an increased risk of future vertebral fractures was equal for prevalent fractures located in either the "lower" (T12-L4) (relative risk [RR] = 2.9; 95% CI = 1.9, 3.6) or "upper" (T4-10) spine (RR = 2.6; 95% CI = 1.9, 3.6). We found no evidence that the effectiveness of alendronate in reducing the risk of future vertebral fracture was attenuated in women with up to five or more prevalent fractures, or that it varied by the location of prevalent fractures. However, prevalent vertebral fractures in any location were more strongly associated with risk of new fractures in the upper (RR = 5.2; 95% CI = 3.2, 8.3) than in the lower spine (2.3; 1.6, 3.3). In addition, each 1 SD decrease in spinal BMD was associated with a 2.1 (1.7, 2.6) times greater odds of new fracture in the upper spine, compared with 1.5 (1.3, 1.8) for the lower spine. These findings suggest that, in older women, osteoporosis may be a stronger risk factor for new fractures in the upper (vs. lower) thoracolumbar spine, although we found no evidence that the location of prior fractures should influence treatment decisions. Physicians should recognize that prior vertebral fractures are a strong risk factor for future fractures, and consider treating such patients to reduce their risk of subsequent fractures.

摘要

椎体骨折是最常见的骨质疏松性骨折,与显著的疼痛和功能障碍相关。既往椎体骨折和低骨密度(BMD)是新发椎体骨折的有力预测因素。利用骨折干预试验(一项抗吸收剂阿仑膦酸钠的随机、安慰剂对照试验)中6082名年龄在55 - 80岁的女性的数据,我们探讨了既往椎体骨折数量与新发骨折风险之间的关联,以及这种关联是否受骨折脊柱部位的影响。未来椎体骨折的风险随着既往骨折数量的增加而增加,独立于年龄和BMD;在安慰剂组中,基线时有五处或更多骨折的女性中,超过一半发生了新发椎体骨折,而既往无椎体骨折的女性中这一比例仅为3.8%。位于“下部”(T12 - L4)(相对风险[RR]=2.9;95%可信区间[CI]=1.9,3.6)或“上部”(T4 - 10)脊柱的既往骨折与未来椎体骨折风险增加的关联程度相同(RR = 2.6;95% CI = 1.9,3.6)。我们没有发现证据表明阿仑膦酸钠在降低未来椎体骨折风险方面的有效性在有五处或更多既往骨折的女性中会减弱,也没有发现其有效性因既往骨折部位而异。然而,任何部位的既往椎体骨折与上部脊柱新发骨折风险的关联(RR = 5.2;95% CI = 3.2,8.3)比下部脊柱(2.3;1.6,3.3)更强。此外,脊柱BMD每降低1个标准差,上部脊柱新发骨折的几率比下部脊柱高2.1(1.7,2.6)倍,下部脊柱为1.5(1.3,1.8)倍。这些发现表明,在老年女性中,骨质疏松可能是胸腰椎上部(相对于下部)新发骨折的更强风险因素,尽管我们没有发现证据表明既往骨折部位应影响治疗决策。医生应认识到既往椎体骨折是未来骨折的有力风险因素,并考虑治疗此类患者以降低其后续骨折的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验